All News #Library
Biotech
Protagenic Therapeutics Moves To OTCQB Venture Market
10 Mar 2026 //
PHARMIWEB
PT00114 Phase 1 Multiple-Dose Study Results
09 Dec 2025 //
PHARMIWEB
Protagenic Therapeutics Completes Phase 1 MAD Study Enrollment
13 Nov 2025 //
PHARMIWEB
Protagenic Therapeutics gets $3.1M from warrant activity
21 May 2025 //
ACCESSWIRE
Protagenic, Phytanix Merge to Form Neuroactive Biotech
19 May 2025 //
ACCESSWIRE
Protagenic Therapeutics to Effect 1-for-14 Reverse Stock Split
29 Apr 2025 //
ACCESSWIRE

Market Place
Sourcing Support